FindTrial
Sign In

Efficacy of ramosetron in preventing postoperative nausea and vomiting: An updated meta-analysis with trial sequential analysis

Efficacy of ramosetron in preventing postoperative nausea and vomiting: An updated meta-analysis with trial sequential analysis - Efficacy of ramosetron in preventing postoperative nausea and vomiting: An updated meta-analysis with trial sequential analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000022979
Enrollment
Unknown
Registered
2016-09-01
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent surgery

Interventions

None listed

Sponsors

Kanagawa Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all randomized controlled trials that tested the efficacy of ramosetron compared with a placebo in the prophylaxis of PONV.

Exclusion criteria

Exclusion criteria: studies which were reported by Fujii et al. studies which did not include details of PON and/or POV.

Design outcomes

Primary

MeasureTime frame
PON and POV between ramosetron and placebo in the early, late, and/or next day periods—

Countries

Japan

Contacts

Public ContactTakahiro Mihara

Kanagawa Children's Medical Center Department of Anesthesiology

miharaxxxtotoro@yahoo.co.jp045-711-2351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026